# UCLA Jonsson Comprehensive Cancer Center

Source: https://nuclide.cc/institutions/ucla-jonsson/  
Nuclide record `ucla-jonsson` (Institution). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)"; commercial use needs a licence.

## TL;DR

Where trastuzumab (Slamon) and palbociclib were developed clinically, and a leader in PSMA PET and melanoma immunotherapy (Ribas).

## Summary

The UCLA Jonsson Comprehensive Cancer Center in Los Angeles holds NCI comprehensive designation and is where trastuzumab was developed clinically through Slamon's HER2 work, where palbociclib entered the clinic, and where Antoni Ribas built a leading melanoma immunotherapy programme in checkpoint and TIL research. Johannes Czernin and Jeremie Calais made it a centre for PSMA PET, Hurvitz ran its breast trials programme before moving to Fred Hutch, and Michael A. Teitell, Amar U. Kishan, Aditya Bardia, Denise R. Aberle and the patient Barbara Bradfield are also listed. Nuclide links it to HER2 and PSMA as targets, to trastuzumab, palbociclib and gallium-68 PSMA-11, and to melanoma and prostate cancer. How to extend the HER2 model of target, drug and companion test to new targets remains its recurring theme. Its HER2, melanoma and PSMA programmes are the ones to read.

## Fields

- Kind: Institution
- Last checked: 2026-09-04
- City: Los Angeles, US
- Type: cancer-center
- NCI designation: comprehensive
- Website: https://www.uclahealth.org/cancer

## Sources

- Official website: https://www.uclahealth.org/cancer

## Connected records

- isotopes: [Gallium-68](https://nuclide.cc/isotopes/ga-68/)
- technologies: [PSMA PET](https://nuclide.cc/technologies/psma-pet/)
- targets: [HER2](https://nuclide.cc/targets/her2/), [PSMA](https://nuclide.cc/targets/psma/)
- people: [Amir Iravani](https://nuclide.cc/people/amir-iravani/), [Jeremie Calais](https://nuclide.cc/people/jeremie-calais/), [Johannes Czernin](https://nuclide.cc/people/johannes-czernin/)
- indications: [Prostate cancer](https://nuclide.cc/indications/prostate/)
- drugs: [Gallium-68 gozetotide (PSMA-11)](https://nuclide.cc/drugs/ga68-psma-11/)
- institutions: [National Cancer Institute (NIH)](https://nuclide.cc/institutions/nci/)

---
JSON: https://nuclide.cc/api/v1/entities/ucla-jonsson.json